Prospects for the use of olfactory mucosa cells in bioprinting for the treatment of spinal cord injuries

World J Clin Cases. 2023 Jan 16;11(2):322-331. doi: 10.12998/wjcc.v11.i2.322.

Abstract

The review focuses on the most important areas of cell therapy for spinal cord injuries. Olfactory mucosa cells are promising for transplantation. Obtaining these cells is safe for patients. The use of olfactory mucosa cells is effective in restoring motor function due to the remyelination and regeneration of axons after spinal cord injuries. These cells express neurotrophic factors that play an important role in the functional recovery of nerve tissue after spinal cord injuries. In addition, it is possible to increase the content of neurotrophic factors, at the site of injury, exogenously by the direct injection of neurotrophic factors or their delivery using gene therapy. The advantages of olfactory mucosa cells, in combination with neurotrophic factors, open up wide possibilities for their application in three-dimensional and four-dimensional bioprinting technology treating spinal cord injuries.

Keywords: Cell therapy; Four-dimensional bioprinting; Injury of spinal cord; Neurotrophic factors; Olfactory mucosa cells; Three-dimensional bioprinting.

Publication types

  • Review